295 related articles for article (PubMed ID: 24631132)
1. Glycated albumin; clinical usefulness.
Koga M
Clin Chim Acta; 2014 Jun; 433():96-104. PubMed ID: 24631132
[TBL] [Abstract][Full Text] [Related]
2. 1,5-Anhydroglucitol and glycated albumin in glycemia.
Koga M
Adv Clin Chem; 2014; 64():269-301. PubMed ID: 24938022
[TBL] [Abstract][Full Text] [Related]
3. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
Sato A
Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
[TBL] [Abstract][Full Text] [Related]
4. Glycated albumin in diabetic patients with chronic kidney disease.
Zheng CM; Ma WY; Wu CC; Lu KC
Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.
Yazdanpanah S; Rabiee M; Tahriri M; Abdolrahim M; Rajab A; Jazayeri HE; Tayebi L
Crit Rev Clin Lab Sci; 2017 Jun; 54(4):219-232. PubMed ID: 28393586
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of glycated albumin as another glycemic control marker.
Koga M; Kasayama S
Endocr J; 2010; 57(9):751-62. PubMed ID: 20724796
[TBL] [Abstract][Full Text] [Related]
7. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
[TBL] [Abstract][Full Text] [Related]
8. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.
Gan T; Liao B; Xu G
J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445
[TBL] [Abstract][Full Text] [Related]
9. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.
Danese E; Montagnana M; Nouvenne A; Lippi G
J Diabetes Sci Technol; 2015 Mar; 9(2):169-76. PubMed ID: 25591856
[TBL] [Abstract][Full Text] [Related]
10. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
[TBL] [Abstract][Full Text] [Related]
11. [Glycated albumin as a marker of glycemia in diabetes and its vascular complications].
Warwas M; Żurawska-Płaksej E; Ciężka D; Piwowar A
Postepy Hig Med Dosw (Online); 2015 May; 69():638-48. PubMed ID: 25983302
[TBL] [Abstract][Full Text] [Related]
12. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
[TBL] [Abstract][Full Text] [Related]
13. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
Sany D; Elshahawy Y; Anwar W
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
[TBL] [Abstract][Full Text] [Related]
14. The Glycated Albumin (GA) to HbA1c Ratio Reflects Shorter-Term Glycemic Control than GA: Analysis of Patients with Fulminant Type 1 Diabetes.
Koga M; Inada S; Nakao T; Kawamori R; Kasayama S
J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27386821
[TBL] [Abstract][Full Text] [Related]
15. Glycated albumin may be a choice, but not an alternative marker of glycated hemoglobin for glycemic control assessment in diabetic patients undergoing maintenance hemodialysis.
Chen FK; Sun XF; Zhang D; Cui SY; Chen XM; Wei RB; Lu JM; Li JJ; Liu WH; Zhang DL; Zhang ZM
Chin Med J (Engl); 2013; 126(17):3295-300. PubMed ID: 24033952
[TBL] [Abstract][Full Text] [Related]
16. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
17. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
18. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
[TBL] [Abstract][Full Text] [Related]
19. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
[TBL] [Abstract][Full Text] [Related]
20. Association between glycated haemoglobin, glycated albumin and fructosamine with neonatal birthweight and large-for-date status infants in gestational diabetes mellitus: a prospective cohort study.
Mendes N; Alves M; Andrade R; Ribeiro RT; Papoila AL; Serrano F
J Obstet Gynaecol; 2019 Aug; 39(6):768-773. PubMed ID: 31007102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
